BioSpace News Archive

Pneuma Respiratory, Inc. has recruited Dr. Steven Kesten as President and Chief Medical Officer.

Upadacitinib significantly inhibited radiographic progression at week 26 compared to placebo

The telemedicine consumer experience takes a giant leap forward with a new solution pioneered by an innovative collaboration between Change Healthcare and Doctor On Demand.

FDA-approved Ethyol® and Totect® address harmful effects of cancer treatments to help improve the quality of life for oncology patients

As a leading exhibition in Medical Device design and manufacturing in China, Medtec China 2018 will take place 26-28 September 2018 at the Shanghai World EXPO Exhibition & Convention Centre.

CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD and Chief Financial Officer, Ms. Kathy Bloch will meet with European investors this week at the H.C. Wainwright Annual Global Life Sciences Conference on April 9-10, 2018 in Monte Carlo, Monaco and in separate meetings in Frankfurt, Germany, as well as Zurich and Geneva, Switzerland on April 11-13, 2018.

DUOBRII Demonstrated Significant Superiority Over Vehicle As Early As Two Weeks

Study meets its primary endpoint

Can-Fite BioPharma Ltd. announced its poster presentation of the anti-inflammatory and anti-fibrogenic effects of Namodenosen in NAFLD/NASH animal model data at the 53rd Annual International Liver Congress of the European Association for the Study of the Liver (EASL) to be held on April 11-15, 2018 at the Paris Porte de Versailles in Paris, France.

Top-line results from placebo-controlled clinical trial expected early in the fourth quarter of 2018